Novo Nordisk
-
GE HealthCare collaborates with Novo Nordisk
To advance novel non-invasive treatment for Type 2 diabetes and obesity with ultrasound GE HealthCare announced a collaboration with Novo…
Read More » -
Novo Nordisk, IIIT Bangalore sign MoU
To drive industry-academia research opportunities and skill development Novo Nordisk Global Business Services (GBS) and the International Institute of Information…
Read More » -
Novo Nordisk India unveils ‘Break the Partnership’ diabetes campaign
The campaign aims to increase awareness of recent treatment choices that manage body weight along with blood glucose in type…
Read More » -
Novo Nordisk India launches GLP-1 RA, Oral Semaglutide, to treat diabetes
Semaglutide, a GLP-1 receptor analogue (GLP-1 RA), indicated for the management of type 2 diabetes has been developed in an…
Read More »
